Elite Pharmaceuticals, Inc. Contract Liability (Deferred Revenue)
Elite Pharmaceuticals, Inc. (ELTP) had Contract Liability (Deferred Revenue) of $2.22 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-06-29
- 2025-06-30: Contract with Customer, Liability, Current $2.22K.
- 2025-03-31: Contract with Customer, Liability, Current $5.56K.
- 2024-12-31: Contract with Customer, Liability, Current $8.89K.
- 2024-09-30: Contract with Customer, Liability, Current $12.22K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2025-06-30 | $2.22K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $5.56K 10-K · filed 2026-06-29 |
| 2024-12-31 | $8.89K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $12.22K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $13.33K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $13.33K 10-K · filed 2025-06-30 |
| 2023-12-31 | $13.33K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $13.33K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $13.33K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $13.33K 10-K · filed 2024-07-01 |
| 2022-12-31 | $13.33K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $13.33K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $13.33K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $13.33K 10-K · filed 2023-06-29 |
| 2021-12-31 | $13.33K 10-Q · filed 2022-02-14 |
| 2021-03-31 | $13.33K 10-K · filed 2022-06-29 |